Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review - Wikidata - wikimedia - TriplyDB

Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review

Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review

http://www.wikidata.org/entity/Q33675546

about

Antimicrobial drug use in food-producing animals and associated human health risks: what, and how strong, is the evidence?Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.Pseudomonas aeruginosa: resistance to the max Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis.Evaluation of the appropriateness of imipenem/cilastatin prescription and dosing in a tertiary care hospital IMP-29, a novel IMP-type metallo-β-lactamase in Pseudomonas aeruginosa Mechanisms of antimicrobial resistance in Gram-negative bacilli.Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.Risk Factors and Outcomes for Intestinal Carriage of AmpC-Hyperproducing Enterobacteriaceae in Intensive Care Unit Patients.Antibiotic Susceptibility Testing of the Gram-Negative Bacteria Based on Flow Cytometry Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies.Pseudomonas aeruginosa in a hydropathic facility: diversity, susceptibility and imipenem resistance mutation.Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens.Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America.Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models.Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals.An antibiotic stewardship exercise in the ICU: building a treatment algorithm for the management of ventilator-associated pneumonia based on local epidemiology and the 2016 Infectious Diseases Society of America/American Thoracic Society guidelines.Expression of ampC, oprD, and mexA, outer membrane protein analysis and carbapenemases in multidrug resistant clinical isolates of Pseudomonas aeruginosa from Egypt.

P2860

Q33870110-7A583086-F700-405D-AB57-F46AF300C52D Q34446914-7CE402F7-CEC0-4FB2-BB3F-49D34A64E705 Q35084559-8EE173C2-0565-45BB-B1D9-C6B99857AD1D Q35146116-8F474332-F47C-483B-B9E4-BC4DDF95E115 Q35229009-894D5067-DA8A-4EF1-A2BB-3A2997753F7D Q35867439-92982B7C-6FEA-4730-839B-2B6F97743A7B Q35935319-CABA7C14-CD35-4B79-B9E2-BEAFE4078DBA Q36078359-C5359DE0-C503-45E2-8933-A102C9539C68 Q36644601-4D9BDFC6-A4B6-456D-8CAB-72F452078DBB Q37124422-1B40A84D-DC00-49A5-A1A0-EA60C66B185A Q37317645-0BDF0A96-FF9E-4B0F-8D8E-A766BCAA02D3 Q37924864-385D74BF-28B4-4F3A-9690-5092061114BA Q38058355-6C57DA8C-78D3-4285-AE8F-17316C3C830E Q38243475-9110F644-C7FB-448A-89D3-F117A05FA9C7 Q39671563-495EA359-5601-482D-9F2B-DA57C373E94E Q40119449-377A830D-BA58-4B21-9F11-B1373FE9808B Q41886730-F6D17EB2-E22F-4F96-A807-9C845C5E9509 Q47566277-DBF1DA23-B668-4B83-A38B-9598F9454DCE Q53842280-A6D28557-14C2-4C69-910D-16D30338A4EF

P2860

Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review

http://www.wikidata.org/entity/Q33675546

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review

@ast

Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review

@en

type

label

Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review

@ast

Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review

@en

prefLabel

Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review

@ast

Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review

@en

P1433

Q33675546-527F3F15-764C-48A0-99C6-9E4C6B4912DD

P1476

Q33675546-2C83B73C-C728-46D1-93C5-AFD8A0607493

P2093

Q33675546-87164FFC-4CD5-466F-861C-813D2B33378D

Q33675546-A03A92FA-C5D4-4113-9ADF-CBA4A6D10491

Q33675546-E1A81991-5AD0-4294-BEA2-73F7ECBE865A

Q33675546-E3D3FADF-C04D-400F-AA05-85E7B84CFDD9

Q33675546-E70F87B0-1670-4A70-ACCD-839B0CA0CBC3

P275

Q33675546-2502FBE8-607A-42B3-8492-DE8D738769CC

P2860

Q33675546-01D8F471-CB87-4590-8F82-FD8958DC5772

Q33675546-04A23C26-5FE7-43D4-B142-2AFEF8A132A9

Q33675546-0E4C7573-8ECE-4852-8A4A-A831D1E8FED9

Q33675546-0EDC6466-8EB1-457C-92A4-A1A953BCA9FC

Q33675546-11D18993-9961-4D6F-9AD8-36D28E17B9D6

Q33675546-131985B0-AFFD-4C75-9D54-300EAD13743A

Q33675546-139D3EB5-532C-4631-9474-ED32F282EBBC

Q33675546-16933A50-F120-4723-A520-D246EEEF23FF

Q33675546-19747267-211C-415E-982E-226D61E11361

Q33675546-1EDA0229-1C47-4F6A-A8AF-42113348DBC7

P2888

Q33675546-C631B884-8B6B-4D69-A24D-2E1CEDF07E8C

P304

Q33675546-1CD76F52-8F17-4176-952A-2F9336633D06

P31

Q33675546-50A40670-A05E-4835-A2A2-3320AEC8BCFE

Q33675546-9B776D6E-F2CF-4C2C-A703-6156F946013F

P356

Q33675546-DE4F83C7-8120-4F92-A4AC-1AF6E1D21C1A

P478

Q33675546-1FAD028B-3D7E-47F1-9926-6BCB26A2359A

P5008

Q33675546-C21F3448-88C1-4293-A21E-7221A55D4C12

P577

Q33675546-F5AEFF20-EFD2-47DC-AD5F-4B72F1ACD272

P5875

Q33675546-8A877E48-4C9C-474A-9984-2A4516B5729C

P6179

Q33675546-F8762FFD-806F-4B44-86F0-DF9445CB21D0

P698

Q33675546-A36E5DA7-5D4F-41AE-8E65-1257DCB552A9

P921

Q33675546-2B6D6E05-9D1F-47A3-B16B-D2E6FF398282

Q33675546-2D7E7952-8198-4941-AA71-68A7009D70CD

Q33675546-75E0F831-E027-4DF2-A2AA-2BA2CF161448

Q33675546-88BFB794-EB31-4BCF-B8D0-88D5C5AD37E5

Q33675546-9D51B4DC-9494-4F34-9684-20BE8C27ACF7

Q33675546-A1C9F01C-9046-4DC2-8F9B-E1001B3AC67B

Q33675546-E4FEB75F-AB31-4E01-B561-F01B20BCEF40

Q33675546-E62D6AF5-DFD3-4A69-A253-6BA93C4139A0

P932

Q33675546-0BED5600-1672-46BA-9A02-C862BC7EFF5E

P356

1471-2466-10-45

P1433

BMC Pulmonary Medicine

P1476

Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review

@en

P2093

Andrew F Shorr

http://www.w3.org/2001/XMLSchema#string

Andrew M Ramsey

http://www.w3.org/2001/XMLSchema#string

Joyce Chen

http://www.w3.org/2001/XMLSchema#string

Marya D Zilberberg

http://www.w3.org/2001/XMLSchema#string

Samir H Mody

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.

Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005

Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.

Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study.

Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin.

Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients.

P2888

1471-2466-10-45

P304

45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2466-10-45

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2010-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46008560

http://www.w3.org/2001/XMLSchema#string

P6179

1012698164

http://www.w3.org/2001/XMLSchema#string

P698

20796312

http://www.w3.org/2001/XMLSchema#string

P921

heterocyclic compound

bacterial pneumonia

physiological phenomena

ventilator-associated pneumonia

P932

2939581

http://www.w3.org/2001/XMLSchema#string